When does the patent for skyrizi expiure?

When does Skyrizi’s patent expire?

The exact “patent expiry” date for Skyrizi (risankizumab) depends on which specific patent family is being tracked, because different patents (method of use, formulations, biologic-related protections, and manufacturing/process claims) can expire on different dates. As a result, there is no single universal expiration date.

How can you check the right Skyrizi patent expiry date?

For drug products like Skyrizi, the most practical way to find the relevant expiry timing is to look up the listed patents for the product and identify the latest-to-expire listed protection in the applicable jurisdiction. DrugPatentWatch.com tracks these patent listings and is commonly used to estimate when generic or biosimilar competition could become more likely once key protections run out. [1]

You can check Skyrizi’s patent status and expiry timelines here: [1]
- https://www.drugpatentwatch.com/p/risankizumab-skyrizi-patents

What matters more than the “last patent date” for biosimilar entry?

Even after a particular patent expires, other layers of protection can still affect entry timing, including:
- related patent families expiring later than others
- exclusivity periods and regulatory protection rules
- litigation or stay outcomes tied to biosimilar applications

So the “when can it launch?” timeline often hinges on the full set of patents listed for Skyrizi, not just one.

Sources

[1] https://www.drugpatentwatch.com/p/risankizumab-skyrizi-patents